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Aims:Biliary neuroendocrine tumors (NETs) are rare and mostly exist as a component of mixed 
adenoneuroendocrine carcinomas (MANECs). Although the NET component in biliary MANECs is 
generally more malignant and clinically more important to the prognosis than the ordinary 
adenocarcinomatous component, the histogenesis of biliary NET has not been clarified. In this study, 
the role of the Notch1-Hes1 signaling axis in the histogenesis of biliary NETs was examined. 
Methods:Immunohistochemistry for Notch1, its ligand Jagged1, and Hes1 was performed using 
surgical specimens from 11 patients with biliary MANEC. Moreover, after the knock-down of 
Notch1 mRNA expression by the siRNA technique in a cholangiocarcinoma cell line, the expression 
of chromogranin A (a neuroendocrine marker) and Ascl1 (a neuroendocrine-inducing molecule 
inhibited by activated Hes1) was examined by quantitative PCR. Results:Histological examination 
revealed that the adenocarcinomatous components were predominately located at the luminal surface 
of the MANEC and the majority of stromal invasion involved NET components. Ordinary 
adenocarcinomas and non-neoplastic biliary epithelium constantly expressed Notch1, Jagged1, and 
Hes1, but the expression of Notch1 and Hes1 was decreased or absent in NET components, 
suggesting interference with the Notch1-Hes1 signaling axis in biliary NET. Moreover, in the 
cholangiocarcinoma cell line in which the expression of Notch1 mRNA was knocked down, the 
mRNA expression of Ascl1 and chromogranin A was increased. Conclusion:The Notch1-Hes1 
signaling axis suppresses neuroendocrine differentiation and maintains tubular/acinar features in 
adenocarcinoma and non-neoplastic epithelium in the biliary tree. Moreover, a disruption of this 
signaling axis may be associated with the tumorigenesis of NETs in biliary MANEC.  
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INTRODUCTION 
 Neuroendocrine tumors (NETs) including carcinoid tumors are commonly found in several 
organs including the pancreas and gastrointestinal tract. In contrast, most tumors originating from 
the intrahepatic and extrahepatic biliary trees are ordinary adenocarcinomas, irrespective of their 
etiology. Physiologically, a few enterochromaffin-like neuroendocrine cells exist in the biliary tree, 
particularly in large bile ducts and peribiliary glands of the hepatic hilus,
1
 but cases of pure NET in 
hepatobiliary organs are very rare. Most biliary NETs exist as a component of mixed 
adenoneuroendocrine carcinomas (MANECs, WHO classification, 2010).
2
 MANECs are found in 
hepatic hilar cholangiocarcinomas with hepatolithiasis, gallbladder cancers, and extrahepatic 
cholangiocarcinomas and show a characteristic histology.
3
 Moreover, since the NET component of 
biliary MANEC defines the prognosis, it is important to identify it and consider indications for 
adjunctive therapy such as somatostatin analogues. 
 Notch signaling allows the establishment of patterns of gene expression and differentiation, 
and regulates cell fate in multiple developmental programs. The Notch signaling pathway has an 
important role in the development of intrahepatic bile ducts via postnatal bile duct growth and 
remodeling.
4
 Moreover, in the developing endoderm, Notch signaling inhibits endocrine 
differentiation via the activation of a repressor, hairy and enhancer or spilt 1 (Hes1, a Notch effector), 
for the expression of a basic helix-loop-helix (bHLH) transcription factor, achaete-scute complex 
homolog-like 1 (Ascl1)/MASH1 which leads to the neuroendocrine phenotype.
5-8
 Therefore, the 
Notch1-Hes1 signaling axis and Ascl1 play key opposing roles and a lack of Notch1 signaling has 
been demonstrated to cause the regression of Hes1 activation leading to the activation of Ascl1 and 
neuroendocrine differentiation in gastrointestinal carcinoids.
7
 
 To date, several cases of biliary NET, mostly MANEC, have been reported,
9-13
 but the 
histogenesis of NETs is not well studied in the biliary tree area. In this study, we first examined the 
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expression of a panel of developmental transcription factors concerned with the Notch1-Hes1 
signaling axis in biliary NET using biliary MANEC cases. Impaired Notch1-Hes1 signaling is 
demonstrated to play a role in the histogenesis of biliary NET. 
 
MATERIALS and METHODS 
 
Patients and tissue preparations 
 Surgically resected hepatobiliary specimens from a total of 11 patients with biliary 
MANECs were retrieved from the surgical files of our laboratories and affiliated hospitals. Six 
patients had gallbladder cancer with cholecystolithiasis, 2 had common bile duct cancer, and 3 had 
hepatic hilar cholangiocarcinoma accompanying hepatolithiasis. Nine of the cases were used in 
another study for the clinicopathological characterization of biliary MANEC.
3
 All tissue specimens 
containing tumorous lesions were immediately fixed in 10% neutral-buffered formalin and 
embedded in paraffin. Several 4µm-thick sections were prepared from each paraffin-embedded block 
and either routinely stained for histologic evaluation or processed for immunohistochemical analysis. 
 
Definition of MANEC 
 According to the WHO classification (2010), at least 30% of the main lesion has to be 
made up of either an adenocarcinoma or NET.
2,14
 Moreover, the NET component must be positive 
for neuroendocrine markers such as chromogranin A and synaptophysin. 
 
Immunohistochemistry 
 Using representative cancerous sections involving NET from each case, the 
immunohistochemical staining of chromogranin A and synaptophysin was performed to confirm the 
Page 4 of 25
http://mc.manuscriptcentral.com/jclinpathol





























































Confidential: For Review Only
      Notch1-Hes1 signaling in biliary NET  - 5 - 
 
presence of NETs. Moreover, Notch1, Jagged1, and Hes1 were also immunostained to examine the 
Notch1-Hes1 signaling axis in the tumorigenesis of biliary NET. The deparaffinized sections were 
microwaved in citrate buffer (pH6) for 20min for antigen retrieval prior to staining. Following 
endogenous peroxidase blocking and incubation in normal goat or rabbit serum (1:10; Vector Lab, 
Burlingame, CA) for 20 min, these sections were incubated at 4°C overnight with primary antibodies 
against human chromogranin A (mouse IgG, 0.5µg/ml, Dako, Tokyo, Japan), synaptophysin (mouse 
IgG, 5µg/ml, Dako), Jagged 1 (Goat IgG, 0.5µg/ml, Santa Cruz, Santa Cruz, CA), Notch 1 (mouse 
IgG, 5µg/ml, OriGene, Rochkville, MD), or HES1 (Rabbit IgG, 5µg/ml, United States Biological, 
Swampscott, MA), and then at room temperature for 1 hour with goat anti-mouse or anti-rabbit 
immunoglobulins conjugated to a peroxidase-labeled dextran polymer (Envision, Dako) or rabbit 
anti-goat immunoglobulins conjugated to a peroxidase-labeled dextran polymer (Simple staining kit, 
Nichirei, Tokyo, Japan). After a benzidine reaction, sections were weakly counterstained with 
hematoxylin. No positive staining was obtained when the primary antibodies were replaced with an 
isotype-matched, non-immunized immunoglobulin as a negative control of the staining procedures. 
The degree of expression of Jagged1 and Notch1 in the adenocarcinoma and NET components was 
semi-quantitatively evaluated as <20%, 20-80%, or >80%.  
 
Cell culture and transfection of short interfering RNAs (siRNA) 
 A commercially available cell line derived from human cholangiocarcinoma, HuCCTl, 
was obtained from Health Science Research Resources Bank (Osaka, Japan). This cell line was 
cultured in culture flasks with a standard medium (RPMI 1640, Life Technologies, Tokyo, Japan) 
supplemented with 10% fetal calf serum at 37
o
C in a water-saturated atmosphere of 95% air and 5% 
CO2. Two kinds of siRNAs against mRNA of Notch 1 (siRNA 1, 
ACGAAGAACAGAAGCACAAAGGCGG and siRNA 2, 
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UCGCAUUGACCAUUCAAACUGGUGG) were purchased from Life Technologies. HuCCT1 was 
transfected the day after plating at 30–40% confluence using Lipofectamine™ (Life Technologies), 
according to the manufacturer’s recommendation. After 48 h, cells were lysed for RNA isolation. 
Notch 1 and Ascl1 transcript levels was analyzed by real-time PCR as described below.  
 
Isolation of RNA and polymerase chain reaction (PCR) 
HuCCT1 was collected from the flasks with a cell scraper for determination of the baseline 
mRNA expression of Notch1, Jagged1, Hes1, Ascl1, and chromogranin A by RT-PCR. Cultured 
normal human intrahepatic biliary epithelial cell lines established in our laboratory
15-17
 and the breast 
cancer cell line MCF1 (Health Science Research Resources Bank) were used as positive controls.
 
Briefly, total RNA was isolated from each sample with the RNeasy
TM
 Total RNA System (QIAGEN, 
Hilden, German) and treated with RNase-Free DNaseI. For reverse transcription (RT), 1µg of total 
RNA, M-MLV RTase (ReverTra Ace, Toyobo, Tokyo, Japan) and oligo-dT primers were used. PCR 
amplification was performed using DNA polymerase (Takara EX Taq, Takara, Tokyo, Japan) and 
specific primers for human mRNA sequences. Following 40 cycles of annealing for 1min and 
extension at 72
o
C for 2min, PCR products were subjected to agarose gel electrophoresis. In addition, 
real-time quantitative PCR was performed for measurements of Notch1, Ascl1, and chromogranin A 
mRNAs according to a standard protocol using the Brilliant II SYBR Green QPCR Reagents and 
Mx300P QPCR system (Stratagene Japan, Tokyo, Japan) and relative gene expression was calculated 
using the comparative cycle threshold method. Specific primers were as follows: Notch1 forward, 
5’-AGCATCACCTGCCTGTTAGG-3’, and reverse, 5’-TGGCATACACACTCCGAGAA-3’, 
Jagged1 forward, 5’-CTTTGCAGCTCAGAACCACA-3’, and reverse, 
5’-CCAGCAACTGCTGACATCAA-3’, Hes1 forward, 5’-TCTGAGCCAGCTGAAAACAC-3’, and 
reverse, 5’-GGTACTTCCCCAGCACACTT-3’, Ascl1 forward, 
5’-TCGCACAACCTGCATCTTTA-3’, and reverse, 5’-CCGTTTTCTGAAAGCCATGT-3’, 
chromogranin A forward, 5’-CGCGCCTTGTCTCCTACTC-3’, and reverse, 
5’-AGGAAAGAGCCCAGAACAGAT-3’, and glyceraldehyde 3 phosphate dehydrogenase 
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(GAPDH, internal positive control), forward, 5’-GGCCTCCAAGGAGTAAGACC-3’, and reverse, 
5’-AGGGGTCTACATGGCAACTG-3’. 
 
Statistical analysis   





Pathology of biliary MANECs 
 The presence of neuroendocrine components was confirmed by the expression of 
chromogranin A and/or synaptophysin using immunohistochemistry and in all MANEC cases 
selected in this study, at least 30% of the main tumor had to be made up of either component. 
Characteristically, the adenocarcinomatous component was located at the luminal surface and the 
majority of the stromal invasion including vascular invasion involved the NET component (Fig.1). 
These NET components were classified as NET G2 or G3 according to the WHO classification 
(2010)
2,14
: the tumor cells had a round- or oval-shaped nucleus and "salt-and-pepper" pattern of 
nuclear chromatin, general characteristics of neuroendocrine cells (Fig.1). 
 
Expression of Notch signaling molecules 
Immunohistochemistry revealed that Jagged1 was constantly expressed in the cytoplasmic 
regions of non-neoplastic biliary epithelial cells in normal bile ducts and gallbladder (Fig.2). 
Although the expression of Jagged1 varied in tumor cells of the adenocarcinoma and NET, 
semiquantitative analysis revealed no significant difference between these components in any cases 
except one (Fig.2). Notch1 was constantly expressed with the nuclear pattern in non-neoplastic 
biliary epithelial cells (Fig.3). In the carcinoma cells composing the ordinary adenocarcinomatous 
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component in biliary MANECs, the expression of Notch1 varied, but in the NET component, all 
cases except one showed <20% positivity (Fig.3). Hes1 expression was found in the cytoplasm 
and/or nucleus of positive cells (Fig.4). Because Hes1 is a transcription factor, its nuclear expression 
indicates the activated form and was evaluated as positivity in this study. Consequently, normal 
biliary epithelial cells and also carcinoma cells of the adenocarcinoma constantly showed positivity. 
In contrast to the ordinary adenocarcinomatous component, in carcinoma cells of the NET 
component, nuclear-type Hes1 expression was lacking in all cases except one (Fig.4).  
 
Expression of Notch signaling molecules and interference of Notch 1 in cultured 
cholangiocarcinoma cells 
 The expression of Notch1, Jagged1, and Hes1 mRNAs was constitutively detected in a 
cultured cholangiocarcinoma cell line, HuCCT1, and normal human intrahepatic biliary epithelial 
cells by the RT-PCR analysis (Fig.5). Ascl1 and chromogranin A were faintly found (Fig.5). The 
procedure using both siRNA1 and siRNA2 against the Notch1 gene interfered with the expression 
approximately 20% (Fig.6). In contrast, the expression of Ascl1 and chromogranin A was 
significantly upregulated, compared to no siRNA (transfectant only) (Fig.6). These findings suggest 




Several cases of biliary NET including carcinoid tumors have been reported, but most 
involve biliary NETs arising from or accompanying ordinary adenocarcinomas (MANEC), mostly in 
patients with gallbladder cancer and extrahepatic cholangiocarcinoma. In cases of biliary MANEC, 
the adenocarcinomatous component was located at the luminal surface of the main tumor and the 
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majority of the stromal invasion including vascular invasion and lymph node metastasis involved the 
NET component. Therefore, we have suggested that the NET component in biliary MANEC defines 
the prognosis.
3
 Although biliary MANEC has a very characteristic histology and it is important to 
identify and consider indications for adjunctive therapy, our understanding of how the 
neuroendocrine phenotype in biliary NETs is regulated is limited. The histogenesis or origins of 
biliary NET including MANEC found in biliary trees may be 1) the ectopic pancreas or adrenal 
gland, 2) metaplastic enterochromaffin-like neuroendocrine cells caused by chronic inflammation, 
and 3) the transformation of adenocarcinoma cells. In the present study, the third hypothesis was 
verified using biliary MANEC cases.  
Notch signaling allows the establishment of patterns of gene expression and differentiation, 
and regulates cell fate in multiple developmental programs. The four mammalian Notch receptors 
(Notch1 to Notch4) are single-pass, heterodimeric transmembrane proteins that serve as receptors for 
Notch ligands, Delta-like (Dll-1, Dll-3, and Dll-4) and Jagged (Jagged1 and Jagged2) expressed on 
neighboring cells. In intrahepatic bile ducts, the Notch signaling pathway has an important role 
during development and a mutation of Jagged1 has been discovered in patients with Alagille 
syndrome.
18
 The present study revealed that non-neoplastic biliary epithelial cells covering 
intrahepatic and extrahepatic bile ducts including gallbladder constantly expressed Notch1 and 
Jagged1 and the expression of Notch1 showed a nuclear pattern suggesting translocation into the 
nucleus from the cytoplasm after the activation of Notch1. Moreover, ordinary adenocarcinomas also 
expressed Notch1 in the nucleus accompanying Jagged1 expression. This suggests that 
adenocarcinomas as well as normal biliary epithelial cells were regulated by Notch1 signaling to 
maintain epithelial homeostasis in the tubular/acinar epithelium.  
 After its activation by Notch ligands expressed on neighboring cells, Notch1 translocates 
to the nucleus and then transactivates target genes including Hes1. In gastrointestinal carcinoids, the 
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overexpression of an active form of Notch1 leads to the up-regulation of Hes1, silencing of Ascl1, 
and the down-regulation of neuroendocrine markers: the regression of the repressor Hes1 followed 
by a lack of Notch signaling has been demonstrated in the histogenesis of NET.
7
 Ascl1 is highly 
expressed in neuroendocrine tumors.
20
 However, this histogenesis of NET is not common in any 
NETs. Wang et al.,
19
 reported that gastroenteropancreatic NETs were heterogeneous with regard to 
the Notch1-HES1 signaling pathway; Notch1 and Hes1 were preferentially expressed in rectal NETs 
and a subset of pancreatic NETs, but uniformly negative in ileal NETs, indicating the heterogeneity 
in signaling pathways of gastroenteropancreatic NETs. Moreover, in the developing endoderm, 
disruption of Notch-Hes1 signaling results in precocious endocrine differentiation in the pancreas. 
Because pancreatico-biliary systems embryologically share the common genesis from the foregut,
21
 
the Notch-Hes1 signaling axis is important in maintaining tubular/acinar function by preventing the 
differentiation into neuroendocrine cells during biliary development. In the present study, we used 
cultured human cholangiocarcinoma HuCCT1 cells, though it is unknown that HuCCT1 is originated 
from intrahepatic or extrahepatic cholangiocarcinoma. Moreover, as a positive control, we used 
human intrahepatic biliary epithelial cells established in our laboratory,
17
 because we could not 
prepare cultured biliary epithelial cells from extrahepatic bile ducts. However, these cultured cells 
constantly expressed Hes1 as well as Notch1 and Jagged1, suggesting that the Notch-Hes1 signaling 
axis could prevent neuroendocrine differentiation to maintain biliary homeostasis. Moreover, this 
study using surgical specimens revealed that ordinary adenocarcinoma components constantly 
expressed Notch1, Jagged1, and Hes1, but the expression of Notch1 and Hes1 was mostly lacking in 
biliary NET components. This finding suggests that Notch-Hes1 signaling is important to inhibit 
neuroendocrine differentiation in the adenocarcinoma phenotype of cholangiocarcinoma and an its 
impairment is closely associated with the tumorigenesis of biliary NETs.  
 As mentioned above, we speculate that the NET component of biliary MANEC originated 
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from adenocarcinoma cells. Therefore, we directly demonstrated that a cultured cholangiocarcinoma 
cell line showing adenocarcinomatous features transformed into NET. Immunohistochemistry using 
MANEC specimens suggested that the Notch1-Hes1 signaling axis prevented the expression of 
neuroendocrine features, although the expression of Jagged1 was preserved in biliary NETs. 
Therefore, the knock-down of Notch1 expression in a cultured cholangiocarcinoma cell line was 
performed by the siRNA technique. Consequently, under conditions where Notch1 expression was 
reduced approximately 20%, the expression of Ascl1 and chromogranin A was significantly 
upregulated. This finding directly demonstrated that the regression of Notch 1 expression could 
result in NET features, probably via Hes1. The mechanism of degression of Notch expression in 
biliary NET is unknown. In prostate carcinoma, neuroendocrine differentiation has been associated 
with tumor progression and a poor prognosis, and induced by hypoxia; Hypoxia triggered a 
significant decrease of Notch expression, with subsequent downregulation of Hes1 and upregulation 
of neuroendocrine markers.
22
 Biliary MANEC is also possibly associated with hypoxia in the 
histogenesis of the NET component.  
 
Take home messages 
-  Notch1-Hes1 signaling axis suppresses neuroendocrine differentiation to maintain tubular/acinar 
features in biliary adenocarcinoma and normal epithelium.  
-  A disruption of Notch1-Hes1 signaling axis may be associated with the tumorigenesis of biliary 
neuroendocrine tumors in mixed adenoneuroendocrine carcinomas. 
-  Further studies are needed to understand the mechanism behind the modulation of Notch1 and to 
devise ways to improve the prognosis for mixed adenoneuroendocrine carcinomas. 
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Fig.1  Gallbladder cancer with neuroendocrine tumor (NET) G3 (WHO classification, 2010). 
Although the luminal surface of the tumor is an ordinary tubular adenocarcinoma (A, arrow), 
the invasive component has a different histology showing a solid component (A, *). Tumors 
in the solid component consist of uniform-sized and large tumor cells resembling large cell 
neuroendocrine carcinoma of the lung (B) and are diffusely positive for chromogranin A (C). 
(A) and (B), H&E staining. (C) Immunohistochemistry for chromogranin A. Original 
magnification, (A) and (C), x40; (B), x400. 
 
Fig.2  Comparative analysis of Jagged1 expression between adenocarcinomas and neuroendocrine 
tumors (NETs) in MANEC. Cytoplasmic expression is diffusely found in both 
adenocarcinomas (A, arrow) and NETs (A, * and B). Non-neoplastic biliary epithelial cells 
lining the intrahepatic large bile duct are also positive (C). Semi-quantitative evaluation 
revealed that the expression varied, but there was no significant difference between the 
adenocarcinoma (Ade.ca.) and NET except in one case (D). Immunohistochemistry for 
Jagged1 (A-C). Original magnification, (A) and (B), x40; (B), x200. 
 
Fig.3  Comparative analysis of Notch1 expression between adenocarcinomas and neuroendocrine 
tumors (NETs). Nuclear expression is found in the adenocarcinomas (A and B, arrows), but 
rarely in NETs (A and B, *). Normal biliary epithelial cells lining the gallbladder are also 
constantly positive for Notch1 with a nuclear pattern. Semi-quantitative evaluation revealed 
that Notch1 expression in NET is decreased in 8 of 11 cases and less than 20% in all cases 
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except one. There was a statistical significant in the expression of Notch 1 between 
adenocarcinoma and NET (Wilcoxon signed-ranks test, p<0.1, T value=2, confidence interval 
5 to 31). Immunohistochemistry for Notch1 (A-C). Original magnification, (A), x40; (B) and 
(C), x200. 
 
Fig.4  Comparative analysis of Hes1 expression between adenocarcinomas and neuroendocrine 
tumors (NETs). Nuclear expression is found in the adenocarcinomas (A and B, arrows), but 
not NETs (A and B, *). Normal biliary epithelial cells lining the gallbladder also constantly 
express Hes1 in a nuclear pattern (C). Evaluation of the Hes1 expression pattern revealed no 
nuclear expression in NET components except one case, though there was a statistical 
significant in the expression of Hes1 between adenocarcinoma and NET (Wilcoxon 
signed-ranks test, p<0.1, T value=5, confidence interval 8 to 37). Immunohistochemistry for 
HES1 (A-C). Original magnification, (A), x40; (B), x400; (C), x200. 
 
 
Fig.5  Detection of Notch1, Jagged1, Hes1, Ascl1, and chromogranin A in cultured human 
intrahepatic biliary epithelial cells (HIBEC), human cholangiocarcinoma cells (HuCCT1), 
and human breast cancer cells (MCF1, positive control) by RT-PCR analysis. All cultured cell 
lines express the mRNAs of Notch1, Jagged1, and Hes1. Although Ascl1 and chromogranin 
A were detected in MCF1, they were only faintly detected in HuCCT1. "NC" was a negative 
control (distilled water instead of the reverse transcriptase for reverse transcription). 
 
Fig.6   Quantitative analysis of mRNAs of Notch1, Ascl1, and chromogranin A in a cultured 
cholangiocarcinoma cell line, HuCCT1. The knock-down of Notch1 mRNA expression by 
approximately 20% using the siRNA technique, increased the expression of Ascl1 and 
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chromogranin A significantly. siRNA1 and siRNA2 interfered with different sites of the 
Notch1 gene, but had similar effects. Results are shown as a percentage compared with no 
siRNA (control). 
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